Deletion within the D17S34 locus in a primitive neuroectodermal tumor

Cancer Research

Volumn 57, Issue 1, 1997, Pages 32-34

  Haataja, Leena ^a   Raffel, Corey ^b   Ledbetter, David H ^c   Tanigami, Akira ^d   Petersen, Denise ^a   Heisterkamp, Nora ^a   Groffen, John ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TELOMERE; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 17; GENE DELETION; GENE REARRANGEMENT; GENETIC MARKERS; GENETIC VECTORS; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE;

EID: 0031015442     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cohen, M. E., and Duffner, P. K. (eds). Brain Tumors in Children: Principles of Diagnosis and Treatment, pp. 177-201 and 377-385. New York: Raven Press, 1994.
2. Raffel, C., Gilles, F. E., and Weinberg, K. I. Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. Cancer Res., 50: 587-591, 1990.
3. Thomas, G. A., and Raffel, C. Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res., 51: 639-643, 1991.
4. Biegel, J. A., Burk, C. D., Ban, F. G., and Emanuel, B. S. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res., 52: 3391-3395, 1992.
5. Raffel, C., Thomas, G. A., Tishler, D. M. Lassoff, S., and Allen, J. C. Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery (Baltimore), 33: 301-305, 1993.
6. McDonald, J. D., Daneshvar, L., Willert, J. R., Matsumura, K., Waldman, F., and Cogen, P. H. Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics, 23: 229-232, 1994.
7. Scheurlen, W. G., Krauss, J., and Kühl, J. No preferential loss of one parental allele of chromosome 17p13.3 in childhood medulloblastoma. Int. J. Cancer, 63: 372-374, 1995.
8. Cogen, P. H., Daneshvar, L., Metzger, A. K., Duyk, G., Edwards, M. S. B., and Sheffield, V. C. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet., 50: 584-589, 1992.
9. Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B., Mackenzie, I. M., Cranston, G., Chetty, U., Mackay, J., Macdonald, M., Nakamura, Y., Hoyheim, B., and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336: 761-763, 1990.
10. Sato, T., Akiyama, F., Sakamoto, G., Kasumi, F., and Nakamura, Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res., 51: 5794-5799, 1991.
11. Andersen, T. I., Gaustad, A., Ottestad, L., Farrants, G. W., Nesland, J. M., Tveit, K. M., and Børresen, A-L. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes, Chromosomes & Cancer, 4: 113-121, 1992.
12. Saxena, A., Clark, W. C., Robertson, J. T., Ikejiri, B., Oldfield, E. H., and Ali, I. U., Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res., 52: 6716-6721, 1992.
13. Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., and Ishizaki, K. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res., 53: 368-372, 1993.
14. Cornelis, R. S., van Vliet, M., Vos, C. B. J., Cleton-Jansen, A-M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Børresen, A-L., Cornelisse, C. J., and Devilee, P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutation. Cancer Res., 54: 4200-4206, 1994.
15. Isomura, M., Tanigami, A., Saito, H., Harada, Y., Katagiri, T., Inazawa, J., Ledbetter, D. H., and Nakamura, Y. Detailed analysis of loss of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers. Genes, Chromosomes & Cancer, 9: 173-179, 1994.
16. Willert, J. R., Daneshvar, L., Sheffield, V. C., and Cogen, P. H. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas. Genes, Chromosomes & Cancer, 12: 165-172, 1995.
17. Morris, C., Benjes, S., Haataja, L., Ledbetter, D. H., Heisterkamp, N., and Groffen, J. Spatial organization of ABR and CRK genes on human chromosome band 17p13.3. Oncogene, 10: 1009-1011, 1995.
18. Kondoleon, S., Vissing, H., Luo, X. Y., Magenis, R. E., Kellogg, J., and Litt, M. A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144-D6 [HGM9 No. D17S34]. Nucleic Acids Res., 15: 10605, 1987.